VC syndicate ploughs $22.6m into Eyegate Pharma
Natixis Private Equity and Emerging Capital have joined existing investors Ventech, Innoven Partners and Medicis Capital in a $22.6m
Natixis Private Equity and Emerging Capital have joined existing investors Ventech, Innoven Partners and Medicis Capital in a $22.6m